Cargando…
Duloxetine in the management of diabetic peripheral neuropathic pain
Diabetic neuropathy affects up to 70% of diabetics, and diabetic peripheral neuropathic pain (DPNP) is the most common and debilitating of the diabetic neuropathies. DPNP significantly reduces quality of life and increases management costs in affected patients. Despite the impact of DPNP, management...
Autores principales: | Ormseth, Michelle J, Scholz, Beth A, Boomershine, Chad S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150163/ https://www.ncbi.nlm.nih.gov/pubmed/21845034 http://dx.doi.org/10.2147/PPA.S16358 |
Ejemplares similares
-
Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009) -
Review of duloxetine in the management of diabetic peripheral neuropathic pain
por: Smith, Timothy, et al.
Publicado: (2007) -
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
por: Zilliox, Lindsay, et al.
Publicado: (2010) -
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
por: King, Jordan B, et al.
Publicado: (2015) -
Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010)